| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 658270 | 68348 | ITNOGEN 2% GEL | ITNOGEN 2% GEL, 1 tubo de 60 g | 20 mg/g | 6 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68348/68348_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68348/68348_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41367 | 44568 | 2007-01-17 | 1 | 1 | 1 | 2007-01-17 | 2007-01-17 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 661952 | 70307 | OLFEN 140 MG APOSITOS ADHESIVOS MEDICAMENTOSOS | OLFEN 140 MG APOSITOS ADHESIVOS MEDICAMENTOSOS, 5 apósitos | 140 mg | 35 | 5 | 69 | 5 apósitos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70307/70307_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70307/70307_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2008-12-11 | 1 | 1 | 1 | 2008-12-11 | 2008-12-11 | 1 | 2015-10-29 | View Edit Delete | ||||||||||||
| 661953 | 70307 | OLFEN 140 MG APOSITOS ADHESIVOS MEDICAMENTOSOS | OLFEN 140 MG APOSITOS ADHESIVOS MEDICAMENTOSOS, 10 apósitos | 140 mg | 35 | 10 | 69 | 10 apósitos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70307/70307_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70307/70307_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2008-12-11 | 1 | 1 | 1 | 2008-12-11 | 2008-12-11 | 1 | 2015-10-29 | View Edit Delete | ||||||||||||
| 766405 | 107395049IP | INVEGA 9 MG COMPRIMIDOS DE LIBERACION PROLONGADA | INVEGA 9 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 9 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/107395049IP/107395049IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/107395049IP/107395049IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6153 | 17193 | 2024-12-03 | 1 | 1 | 1 | 2024-12-04 | 2024-12-03 | 1 | 2025-06-25 | View Edit Delete | ||||||||||||
| 767306 | 107395049IP1 | INVEGA 9 MG COMPRIMIDOS DE LIBERACION PROLONGADA | INVEGA 9 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 9 mg | 110 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/107395049IP1/107395049IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/107395049IP1/107395049IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6153 | 23628 | 2025-03-24 | 1 | 1 | 1 | 2025-03-25 | 2025-03-24 | 1 | 2025-05-14 | View Edit Delete |